Navigation Links
Hospitals Adopt STERIS Advanced Room Sterilization Technology in the Fight Against 'Superbugs'
Date:10/24/2007

VaproSure Room Sterilizers Offer an Innovative Solution in Efforts to

Reduce Healthcare-Associated Infections

MENTOR, Ohio, Oct. 24 /PRNewswire-FirstCall/ -- STERIS Corporation (NYSE: STE) announced today it has received the first orders for its VaproSure(TM) Room Sterilizer from several U.S. hospitals. The VaproSure Room Sterilizer incorporates STERIS patented technologies and is the first product of its kind for the healthcare market. Since being introduced in June of this year, systems have been ordered by Wellmont Health System (Virginia, Tennessee, Kentucky) Lake Hospital System (Ohio), and the VA Boston Healthcare System (Massachusetts). These hospitals are demonstrating leadership in patient safety and infection control and will use their VaproSure Room Sterilizers to sterilize all the exposed surfaces in critical hospital rooms.

As highlighted in recent national news media reports, the persistent spread of germs and infections in healthcare facilities is a significant challenge for patient safety and compromises the ability for hospitals to deliver economically efficient healthcare services. According to the U.S. Centers for Disease Control and Prevention (CDC), it is estimated that one in every 20 patients in the U.S. contracts an infection while in the hospital, resulting in 99,000 deaths each year with costs to the U.S. healthcare industry estimated at $30 billion per year.

Earlier this month, The Journal of the American Medical Association (JAMA) published study results indicating that drug-resistant staph MRSA is killing more people in the United States each year than the AIDS virus.

Commenting on JAMA's findings in The Washington Post, Scott K. Fridkin, a medica
'/>"/>

SOURCE STERIS Corporation
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Midwest shines among best hospitals in U.S.
2. Tech Digest: Inacom; St. Michaels, St. Clares hospitals; Merge eMed; Advanced Data-Comm; Blue Cross and Blue Shield
3. Digitizing hospitals with the right tools
4. GE Healthcare launches new medical scanner, places another in hospitals
5. TeraMedica offers system integration tool for hospitals
6. TDS Helps Florida Hospitals Implement High-Speed VPN
7. IRS ruling could speed healthcare technology adoption
8. DHC 2007: Without fuller IT adoption, health costs might drain Americas wealth
9. Doyle seeks $30M for e-medical record adoption
10. Wisconsin firms wont rush to adopt Microsoft Vista
11. Businesses are slow to adopt Web 2.0 concepts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Toronto, Canada (PRWEB) May 24, 2013 ... selective barriers, and uptake or efflux transporters at the ... may be related to unbound fractions in the tissue ... understanding of these disposition challenges is required to guide ... and to identify any species-dependent variables that may impact ...
(Date:5/24/2013)... Vestiage, Inc. (stock symbol "VEST") a publicly traded ... development, sales and marketing of premium branded highly ... it is awarding exclusive Vestiage territories in the ... Illuminating Facial Care. Qualified applicants can request an ... to info(at)vestiageinc(dot)com and putting RELUMA in the "Subject" ...
(Date:5/23/2013)... , May 24, 2013 Die ... – Bei der englischen Version ... , 91 % der Teilnehmer einer groß angelegten Asthmaumfrage ... % laut GINA [*] -Definition [1] als kontrolliert ... mit Asthma generell einer von vier Denkweisen zugeordnet werden ...
(Date:5/23/2013)... 23, 2013 Venaxis, Inc. (Nasdaq:   APPY), ... obtaining FDA clearance and commercializing its rapid, protein biomarker-based ... of an underwritten public offering of 10,000,000 shares of ... shares of its common stock at an exercise price ... price of $1.25 per share and related warrant.  Venaxis ...
Breaking Biology Technology:DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3
... /PRNewswire-FirstCall/ - Nventa,Biopharmaceuticals Corporation (TSX: NVN) today ... initiated dosing of the second cohort of,patients ... examining the safety of its,lead candidate, HspE7, ... to,cervical cancer. HspE7 is an investigational therapeutic ...
... there has been growing interest in the question, if ... via manure application is of environmental relevance. In a ... journal CLEAN, Kreuzig and co-workers now focused on the ... to the so far available data set on fate ...
... Dec. 5 The American Society of,Hematology (ASH), ... more than 20,000 attendees at the 49th ASH ... World Congress Center in,Atlanta. The meeting will premiere ... "The ASH annual meeting is the premier forum ...
Cached Biology Technology:Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial 2Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial 3Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial 4Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial 5New insights into the fate of anti-parasitics in manure and manured soils 249th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases 249th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases 3
(Date:5/24/2013)... system to combat metastatic cancer , Cancer cells ... the immune system. Stimulation of the immune system can ... factors that cause the immune system to ignore cancer ... to suppress the immune system response. In this issue ... led by Ronald Levy at Stanford University found that ...
(Date:5/24/2013)... scientists from around the world today issued a stark ... of one or two generations, the majority of the ... the handicap of severe pressure on fresh water, an ... substitute. This handicap will be self-inflicted and is, we ... chronic underlying problems led by mismanagement and sent a ...
(Date:5/23/2013)... at Rollins School of Public Health at Emory ... of Technology, have received a $4 million grant ... at Emory University (Health and Exposome Research Center: ... exposome-based center grant awarded in the United States. ... the National Institute of Environmental Health Sciences (NIEHS) ...
Breaking Biology News(10 mins):JCI early table of contents for May 24, 2013 2JCI early table of contents for May 24, 2013 3JCI early table of contents for May 24, 2013 4JCI early table of contents for May 24, 2013 5JCI early table of contents for May 24, 2013 6JCI early table of contents for May 24, 2013 7JCI early table of contents for May 24, 2013 8A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
... you,re a dieter. Chronic dieters tend to ... according to a new study in the Journal ... M. Nowlis, Naomi Mandel, and Andrea C. Morales (all ... food packages that are marketed to help people control ...
... deceivingeven in life,s tiniest critters. From first detection in ... its recent characterization by the U.S. Department of Energy Joint ... adhaerens, appears to harbor a far more complex suite of ... August 21 online edition of the journal Nature, ...
... Scientists at The University of Manchester have developed a ... technology that could lead to quick testing for serious ... of new drugs. Researchers working at the Manchester ... unveiled a new technique for producing functional ,protein chips, ...
Cached Biology News:M&Ms as diet food? 100-calorie pack misconceptions 2Genome of simplest animal reveals ancient lineage, confounding array of complex capabilities 2Genome of simplest animal reveals ancient lineage, confounding array of complex capabilities 3Chips are down as Manchester makes protein scanning breakthrough 2
... ZMD.368. Immunogen: Synthetic peptide derived ... human WNT2B/WNT13 protein. Specificity: Specific ... and rat WNT2B/WNT13 proteins. Recognizes both ... Reactivity: Mouse Human Rat (positive controls: ...
Immunogen: Heat inactivated bacterial cells of Salmonella enteriditis,paratyphi and typhimurium Storage: 4 C...
Immunogen: Secretory component isolated from human colostrum. Storage: 4 C...
... I-96 Plate can be used either in ... large-scale (i.e., 96-well) purification of DNA and/or ... unique silica-based matrix make it perfect for ... RNA in = 10 l eluate per ...
Biology Products: